Gurit Holding（0QQR）株式概要グリット・ホールディングAGは、その子会社とともに、スイス国内および国際的な先進複合材料、複合工具設備、コアキッティング・サービスの開発、製造、供給、マーケティング、販売を行っている。 詳細0QQR ファンダメンタル分析スノーフレーク・スコア評価3/6将来の成長3/6過去の実績0/6財務の健全性4/6配当金0/6報酬収益は年間87.97%増加すると予測されています 同業他社や業界と比較して、良好な取引価格 リスク分析UK市場と比較した過去 3 か月間の株価の変動多額の負債を抱えている すべてのリスクチェックを見る0QQR Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair ValueCHF Current PriceCHF 37.9066.9% 割安 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-60m579m2016201920222025202620282031Revenue CHF 356.7mEarnings CHF 33.5mAdvancedSet Fair ValueView all narrativesGurit Holding AG 競合他社SynthomerSymbol: LSE:SYNTMarket cap: UK£175.1mTreattSymbol: LSE:TETMarket cap: UK£177.7mIofinaSymbol: AIM:IOFMarket cap: UK£92.1mVictrexSymbol: LSE:VCTMarket cap: UK£550.3m価格と性能株価の高値、安値、推移の概要Gurit Holding過去の株価現在の株価CHF 37.9052週高値CHF 45.9052週安値CHF 10.20ベータ1.261ヶ月の変化3.81%3ヶ月変化47.61%1年変化108.13%3年間の変化-56.87%5年間の変化-84.34%IPOからの変化-21.94%最新ニュースBuy Or Sell Opportunity • Apr 21Now 22% overvalued after recent price riseOver the last 90 days, the stock has risen 166% to CHF39.00. The fair value is estimated to be CHF31.90, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 13% over the last 3 years. Meanwhile, the company became loss making.Buy Or Sell Opportunity • Mar 30Now 24% overvalued after recent price riseOver the last 90 days, the stock has risen 228% to CHF37.85. The fair value is estimated to be CHF30.56, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 13% over the last 3 years. Meanwhile, the company became loss making.お知らせ • Mar 23Gurit Holding AG, Annual General Meeting, Apr 16, 2026Gurit Holding AG, Annual General Meeting, Apr 16, 2026, at 16:30 W. Europe Standard Time.Reported Earnings • Mar 05Full year 2025 earnings released: CHF12.90 loss per share (vs CHF5.97 loss in FY 2024)Full year 2025 results: CHF12.90 loss per share (further deteriorated from CHF5.97 loss in FY 2024). Revenue: CHF319.6m (down 26% from FY 2024). Net loss: CHF60.3m (loss widened 116% from FY 2024). Revenue is forecast to grow 2.5% p.a. on average during the next 3 years, compared to a 11% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 82 percentage points per year, which is a significant difference in performance.お知らせ • Dec 16Gurit Holding AG to Report First Half, 2026 Results on Aug 26, 2026Gurit Holding AG announced that they will report first half, 2026 results on Aug 26, 2026Reported Earnings • Aug 23First half 2025 earnings released: CHF14.59 loss per share (vs CHF0.02 loss in 1H 2024)First half 2025 results: CHF14.59 loss per share (further deteriorated from CHF0.02 loss in 1H 2024). Revenue: CHF164.7m (down 23% from 1H 2024). Net loss: CHF68.2m (loss widened CHF68.1m from 1H 2024). Revenue is expected to fall by 3.5% p.a. on average during the next 3 years compared to a 17% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 91 percentage points per year, which is a significant difference in performance.最新情報をもっと見るRecent updatesBuy Or Sell Opportunity • Apr 21Now 22% overvalued after recent price riseOver the last 90 days, the stock has risen 166% to CHF39.00. The fair value is estimated to be CHF31.90, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 13% over the last 3 years. Meanwhile, the company became loss making.Buy Or Sell Opportunity • Mar 30Now 24% overvalued after recent price riseOver the last 90 days, the stock has risen 228% to CHF37.85. The fair value is estimated to be CHF30.56, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 13% over the last 3 years. Meanwhile, the company became loss making.お知らせ • Mar 23Gurit Holding AG, Annual General Meeting, Apr 16, 2026Gurit Holding AG, Annual General Meeting, Apr 16, 2026, at 16:30 W. Europe Standard Time.Reported Earnings • Mar 05Full year 2025 earnings released: CHF12.90 loss per share (vs CHF5.97 loss in FY 2024)Full year 2025 results: CHF12.90 loss per share (further deteriorated from CHF5.97 loss in FY 2024). Revenue: CHF319.6m (down 26% from FY 2024). Net loss: CHF60.3m (loss widened 116% from FY 2024). Revenue is forecast to grow 2.5% p.a. on average during the next 3 years, compared to a 11% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 82 percentage points per year, which is a significant difference in performance.お知らせ • Dec 16Gurit Holding AG to Report First Half, 2026 Results on Aug 26, 2026Gurit Holding AG announced that they will report first half, 2026 results on Aug 26, 2026Reported Earnings • Aug 23First half 2025 earnings released: CHF14.59 loss per share (vs CHF0.02 loss in 1H 2024)First half 2025 results: CHF14.59 loss per share (further deteriorated from CHF0.02 loss in 1H 2024). Revenue: CHF164.7m (down 23% from 1H 2024). Net loss: CHF68.2m (loss widened CHF68.1m from 1H 2024). Revenue is expected to fall by 3.5% p.a. on average during the next 3 years compared to a 17% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 91 percentage points per year, which is a significant difference in performance.お知らせ • Aug 21Gurit Holding AG to Report Fiscal Year 2025 Final Results on Mar 02, 2026Gurit Holding AG announced that they will report fiscal year 2025 final results at 7:00 AM, Central European Standard Time on Mar 02, 2026お知らせ • Apr 17Gurit Holding AG Elects Dr. Libo Zhang as New Member of the Board of DirectorsGurit Holding AG at its AGM held on April 15, 2025, the shareholders elected Dr. Libo Zhang as a new member of the Board of Directors.お知らせ • Apr 01Gurit Holding AG Announces Chief Executive Officer Changes, Effective July 1, 2025Gurit Holding AG announced the appointment of Dr. Tobias Lührig, a German national, as its new Chief Executive Officer, effective July 1, 2025. Dr. Javier Perez-Freije, CFO and current acting CEO ad interim, will continue to lead the company until Tobias Lührig officially starts, after which Javier Perez-Freije will return to the sole role as Chief Financial Officer. With over 20 years of leadership experience in family-owned and private equity-backed companies, Tobias Lührig has a proven track record in operational efficiency, strategic realignment, and margin enhancement. His expertise in right-sizing, fostering resilience during transitions, and aligning global operations makes him the ideal leader for Gurit's ongoing realignment. Tobias Lührig holds a Ph.D. in Mechanical Engineering and an Executive MBA from Harvard Business School. Currently serving as CEO of Bischof+Klein International SE, he combines his engineering, financial, and consulting expertise with a commitment to continuous improvement and corporate culture transformation, which will help to position Gurit for future excellence and growth.お知らせ • Mar 24Gurit Holding AG, Annual General Meeting, Apr 15, 2025Gurit Holding AG, Annual General Meeting, Apr 15, 2025, at 16:30 W. Europe Standard Time.Reported Earnings • Mar 06Full year 2024 earnings released: CHF5.97 loss per share (vs CHF1.59 profit in FY 2023)Full year 2024 results: CHF5.97 loss per share (down from CHF1.59 profit in FY 2023). Revenue: CHF431.7m (down 6.1% from FY 2023). Net loss: CHF27.9m (down 475% from profit in FY 2023). Revenue is forecast to grow 1.0% p.a. on average during the next 3 years, compared to a 3.8% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 54 percentage points per year, which is a significant difference in performance.New Risk • Dec 27New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of British stocks, typically moving 13% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.3x net interest cover). Share price has been highly volatile over the past 3 months (13% average weekly change). Minor Risks Dividend is not well covered by earnings (dividend per share is over 8x earnings per share). Market cap is less than US$100m (CHF71.0m market cap, or US$78.7m).New Risk • Nov 07New minor risk - Dividend sustainabilityThe dividend is not well covered by earnings. Dividend per share is over 8x earnings per share. Dividend yield: 2.3% This is considered a minor risk. Companies that pay out too much of their earnings are at risk of having to reduce or cut their dividend in future. If earnings growth slows or earnings fall, then there may not be enough earnings to maintain the same dividend. Or in extreme cases, companies may opt to dig into capital reserves or take on debt to maintain the dividend. However, this risk is mitigated by the fact the dividend is covered by cash flows. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.3x net interest cover). Minor Risks Dividend is not well covered by earnings (dividend per share is over 8x earnings per share). Share price has been volatile over the past 3 months (8.4% average weekly change). Market cap is less than US$100m (CHF71.4m market cap, or US$81.4m).New Risk • Nov 04New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: CHF81.4m (US$94.2m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.3x net interest cover). Minor Risks Share price has been volatile over the past 3 months (8.8% average weekly change). Market cap is less than US$100m (CHF81.4m market cap, or US$94.2m).お知らせ • Oct 31+ 2 more updatesGurit Holding AG to Report Q3, 2025 Results on Oct 23, 2025Gurit Holding AG announced that they will report Q3, 2025 results at 6:00 PM, Central European Standard Time on Oct 23, 2025New Risk • Oct 09New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 2.3x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.3x net interest cover). Minor Risk Share price has been volatile over the past 3 months (8.1% average weekly change).Valuation Update With 7 Day Price Move • Sep 09Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to CHF29.10, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 10x in the Chemicals industry in the United Kingdom. Total loss to shareholders of 84% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CHF53.01 per share.Valuation Update With 7 Day Price Move • Aug 21Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to CHF35.45, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 10x in the Chemicals industry in the United Kingdom. Total loss to shareholders of 82% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CHF53.03 per share.New Risk • Aug 05New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of British stocks, typically moving 7.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks High level of debt (74% net debt to equity). Share price has been volatile over the past 3 months (7.0% average weekly change).Upcoming Dividend • Apr 15Upcoming dividend of CHF0.35 per shareEligible shareholders must have bought the stock before 22 April 2024. Payment date: 24 April 2024. Trailing yield: 0.6%. Lower than top quartile of British dividend payers (6.1%). Lower than average of industry peers (2.9%).New Risk • Mar 04New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 1.8x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. This is currently the only risk that has been identified for the company.お知らせ • Sep 23+ 2 more updatesGurit Holding AG to Report First Half, 2024 Results on Aug 19, 2024Gurit Holding AG announced that they will report first half, 2024 results on Aug 19, 2024Reported Earnings • Aug 31First half 2023 earnings released: EPS: CHF1.54 (vs CHF3.61 in 1H 2022)First half 2023 results: EPS: CHF1.54 (down from CHF3.61 in 1H 2022). Revenue: CHF244.6m (up 4.2% from 1H 2022). Net income: CHF7.19m (down 57% from 1H 2022). Profit margin: 2.9% (down from 7.2% in 1H 2022). Revenue is forecast to grow 5.3% p.a. on average during the next 3 years, compared to a 5.0% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 92 percentage points per year, which is a significant difference in performance.お知らせ • Aug 18Gurit Holding AG (SWX:GURN) acquired additional 40% stake in Fiberline Building Profiles A/S from Thorning family for €28.15 million.Gurit Holding AG (SWX:GURN) acquired additional 40% stake in Fiberline Building Profiles A/S from Thorning family for €28.15 million on August 15, 2023. The purchase price of €28.15 million includes a cash consideration and a longer term earn-out.Gurit Holding AG (SWX:GURN) completed the acquisition of additional 40% stake in Fiberline Building Profiles A/S from Thorning family on August 15, 2023.お知らせ • Nov 25+ 1 more updateGurit Holding AG to Report First Half, 2023 Results on Aug 16, 2023Gurit Holding AG announced that they will report first half, 2023 results on Aug 16, 2023Board Change • Nov 16No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 6 non-independent directors. Director Andreas Evertz was the last director to join the board, commencing their role in 2022. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.Valuation Update With 7 Day Price Move • Oct 18Investor sentiment improved over the past weekAfter last week's 19% share price gain to CHF97.50, the stock trades at a forward P/E ratio of 27x. Average forward P/E is 16x in the Chemicals industry in the United Kingdom. Total loss to shareholders of 24% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CHF110 per share.Valuation Update With 7 Day Price Move • Sep 29Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to CHF70.30, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 17x in the Chemicals industry in the United Kingdom. Total loss to shareholders of 45% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CHF116 per share.Buying Opportunity • Sep 05Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 8.3%. The fair value is estimated to be CHF120, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 5.1% over the last 3 years. Earnings per share has declined by 64%. Revenue is forecast to grow by 37% in 2 years. Earnings is forecast to grow by 39% in the next 2 years.Reported Earnings • Aug 19First half 2022 earnings releasedFirst half 2022 results: Revenue: CHF234.8m (down 9.2% from 1H 2021). Net income: CHF16.9m (up 41% from 1H 2021). Profit margin: 7.2% (up from 4.6% in 1H 2021). Over the next year, revenue is forecast to grow 17% compared to a 21% decline forecast for the Chemicals industry in the United Kingdom.お知らせ • Jul 09+ 1 more updateGurit Holding AG to Report Fiscal Year 2022 Results on Jan 30, 2023Gurit Holding AG announced that they will report fiscal year 2022 results on Jan 30, 2023Board Change • Apr 27No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 6 non-independent directors. Director Andreas Evertz was the last director to join the board, commencing their role in 2022. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.Upcoming Dividend • Apr 15Upcoming dividend of CHF7.00 per shareEligible shareholders must have bought the stock before 22 April 2022. Payment date: 26 April 2022. Payout ratio is a comfortable 29% but the company is not cash flow positive. Trailing yield: 0.5%. Lower than top quartile of British dividend payers (4.6%). Lower than average of industry peers (2.6%).Valuation Update With 7 Day Price Move • Mar 03Investor sentiment improved over the past weekAfter last week's 16% share price gain to CHF1,520, the stock trades at a forward P/E ratio of 29x. Average forward P/E is 20x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 56% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CHF610 per share.Reported Earnings • Mar 02Full year 2021 earnings: Revenues in line with analyst expectationsFull year 2021 results: Revenue: CHF467.9m (down 19% from FY 2020). Net income: CHF11.4m (down 76% from FY 2020). Profit margin: 2.4% (down from 8.1% in FY 2020). The decrease in margin was driven by lower revenue. Revenue was in line with analyst estimates. Over the next year, revenue is forecast to grow 3.6% compared to a 3.9% decline forecast for the industry in the United Kingdom.Board Change • Sep 25No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 6 non-independent directors. Non-Executive Director Rudolf Hadorn was the last director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.Upcoming Dividend • Apr 09Upcoming dividend of CHF30.00 per shareEligible shareholders must have bought the stock before 16 April 2021. Payment date: 20 April 2021. Trailing yield: 1.2%. Lower than top quartile of British dividend payers (4.2%). Lower than average of industry peers (1.6%).Is New 90 Day High Low • Mar 05New 90-day low: CHF2,255The company is down 6.0% from its price of CHF2,395 on 04 December 2020. The British market is up 4.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 15% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CHF1,069 per share.Reported Earnings • Mar 04Full year 2020 earnings released: EPS CHF99.28 (vs CHF96.83 in FY 2019)The company reported a solid full year result with improved earnings and revenues, although profit margins were flat. Full year 2020 results: Revenue: CHF576.7m (up 3.3% from FY 2019). Net income: CHF46.4m (up 2.6% from FY 2019). Profit margin: 8.1% (in line with FY 2019). Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has increased by 36% per year, which means it is tracking significantly ahead of earnings growth.Analyst Estimate Surprise Post Earnings • Mar 04Revenue misses expectationsRevenue missed analyst estimates by 1.1%. Over the next year, revenue is forecast to grow 2.3% compared to a 12% decline forecast for the Chemicals industry in the United Kingdom.Is New 90 Day High Low • Jan 14New 90-day high: CHF2,690The company is up 33% from its price of CHF2,015 on 16 October 2020. The British market is up 14% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 10.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CHF2,057 per share.Is New 90 Day High Low • Dec 29New 90-day high: CHF2,500The company is up 31% from its price of CHF1,910 on 29 September 2020. The British market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 11% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CHF2,024 per share.お知らせ • Dec 12Gurit Holding AG to Report First Half, 2021 Results on Aug 17, 2021Gurit Holding AG announced that they will report first half, 2021 results on Aug 17, 2021お知らせ • Dec 11Gurit Holding AG to Report Fiscal Year 2020 Results on Mar 02, 2021Gurit Holding AG announced that they will report fiscal year 2020 results at 7:00 AM, Central European Standard Time on Mar 02, 2021Valuation Update With 7 Day Price Move • Dec 10Market pulls back on stock over the past weekAfter last week's 61% share price decline to CHF879, the stock is trading at a trailing P/E ratio of 25x, down from the previous P/E ratio of 64.5x. This compares to an average P/E of 40x in the Chemicals industry in the United Kingdom. Total return to shareholders over the past three years is a loss of 6.1%.Valuation Update With 7 Day Price Move • Dec 07Market pulls back on stock over the past weekAfter last week's 61% share price decline to CHF879, the stock is trading at a trailing P/E ratio of 24.7x, down from the previous P/E ratio of 64x. This compares to an average P/E of 39x in the Chemicals industry in the United Kingdom. Total return to shareholders over the past three years is a loss of 6.1%.Valuation Update With 7 Day Price Move • Nov 30Market pulls back on stock over the past weekAfter last week's 58% share price decline to CHF879, the stock is trading at a trailing P/E ratio of 22.7x, down from the previous P/E ratio of 53.6x. This compares to an average P/E of 38x in the Chemicals industry in the United Kingdom. Total return to shareholders over the past three years is a loss of 8.3%.Valuation Update With 7 Day Price Move • Nov 26Market pulls back on stock over the past weekAfter last week's 57% share price decline to CHF879, the stock is trading at a trailing P/E ratio of 20.9x, down from the previous P/E ratio of 48.7x. This compares to an average P/E of 37x in the Chemicals industry in the United Kingdom. Total return to shareholders over the past three years is a loss of 9.1%.Valuation Update With 7 Day Price Move • Nov 20Market pulls back on stock over the past weekAfter last week's 54% share price decline to CHF879, the stock is trading at a trailing P/E ratio of 21.1x, down from the previous P/E ratio of 45.7x. This compares to an average P/E of 39x in the Chemicals industry in the United Kingdom. Total return to shareholders over the past three years is a loss of 8.6%.Is New 90 Day High Low • Nov 20New 90-day low: CHF879The company is down 48% from its price of CHF1,688 on 20 August 2020. The British market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 8.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CHF767 per share.Valuation Update With 7 Day Price Move • Nov 13Market pulls back on stock over the past weekAfter last week's 56% share price decline to CHF879, the stock is trading at a trailing P/E ratio of 19.6x, down from the previous P/E ratio of 45x. This compares to an average P/E of 39x in the Chemicals industry in the United Kingdom. Total return to shareholders over the past three years is a loss of 7.7%.Valuation Update With 7 Day Price Move • Nov 07Market pulls back on stock over the past weekAfter last week's 54% share price decline to CHF879, the stock is trading at a trailing P/E ratio of 20.6x, down from the previous P/E ratio of 45.1x. This compares to an average P/E of 39x in the Chemicals industry in the United Kingdom. Total return to shareholders over the past three years is a loss of 17%.Is New 90 Day High Low • Oct 30New 90-day low: CHF879The company is down 46% from its price of CHF1,616 on 30 July 2020. The British market is down 4.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 4.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CHF811 per share.Valuation Update With 7 Day Price Move • Oct 30Market pulls back on stock over the past weekAfter last week's 56% share price decline to CHF879, the stock is trading at a trailing P/E ratio of 19.8x, down from the previous P/E ratio of 45.1x. This compares to an average P/E of 38x in the Chemicals industry in the United Kingdom. Total return to shareholders over the past three years is a loss of 17%.Is New 90 Day High Low • Oct 01New 90-day high: CHF2,025The company is up 45% from its price of CHF1,398 on 03 July 2020. The British market is down 4.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 12% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CHF1,867 per share.お知らせ • Aug 17Gurit Announces the Appointment of Mitja Schulz as Chief Executive OfficerGurit announced the appointment of Mitja Schulz as Chief Executive Officer and Member of the Executive Committee. As communicated on April 23, 2020, Gurit has been in the process of recruiting the successor of current Chief Executive Officer Rudolf Hadorn. On August 17, 2020, it was announced that Mitja Schulz has been appointed to fill the position. Prior to joining Gurit, Mitja Schulz was Senior Vice President and CEO of ZF Wind Power Antwerpen NV, part of ZF Friedrichshafen. Before this, he held a number of senior management positions within ZF Friedrichshafen and Porschewhere he successfully executed major business transformation and growth programs.株主還元0QQRGB ChemicalsGB 市場7D-1.6%4.7%1.4%1Y108.1%8.7%19.5%株主還元を見る業界別リターン: 0QQR過去 1 年間で8.7 % の収益を上げたUK Chemicals業界を上回りました。リターン対市場: 0QQR過去 1 年間で19.5 % の収益を上げたUK市場を上回りました。価格変動Is 0QQR's price volatile compared to industry and market?0QQR volatility0QQR Average Weekly Movement12.0%Chemicals Industry Average Movement8.0%Market Average Movement5.8%10% most volatile stocks in GB Market12.0%10% least volatile stocks in GB Market3.1%安定した株価: 0QQRの株価は、 UK市場と比較して過去 3 か月間で変動しています。時間の経過による変動: 0QQRの weekly volatility ( 12% ) は過去 1 年間安定していますが、依然としてUKの株式の 75% よりも高くなっています。会社概要設立従業員CEO（最高経営責任者ウェブサイト18351,925Tobias Lührigwww.gurit.comグリット・ホールディングAGは、その子会社とともに、スイス国内および国際的な先端複合材料、複合材料ツーリング機器、コアキッティング・サービスの開発、製造、供給、マーケティング、販売を行っている。同社はマニュファクチャリング・ソリューションズ、風力材料、海洋・産業分野で事業を展開している。構造用コア材、含浸済み材料、補強材を提供している。また、エンジニアリングサービス、大型プラグと金型、風力ブレードの製造自動化、製造インテリジェンスサービスなどの風力タービンブレード金型と自動化サービス、接着剤、インモールドゲルコート、ラミネート、多目的システムも提供している。さらに、風力ブレード・ソリューション用のコア材キッティング、構造複合材エンジニアリング・サービスも提供している。同社は風力タービン、輸送、海洋、産業、建築、建設、その他の複合材応用産業にサービスを提供している。Gurit Holding AGは1835年に設立され、スイスのワットヴィルに本社を置いている。もっと見るGurit Holding AG 基礎のまとめGurit Holding の収益と売上を時価総額と比較するとどうか。0QQR 基礎統計学時価総額CHF 178.91m収益（TTM）-CHF 60.32m売上高(TTM)CHF 319.57m0.6xP/Sレシオ-3.0xPER（株価収益率0QQR は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計0QQR 損益計算書（TTM）収益CHF 319.57m売上原価CHF 250.01m売上総利益CHF 69.56mその他の費用CHF 129.87m収益-CHF 60.32m直近の収益報告Dec 31, 2025次回決算日Aug 26, 2026一株当たり利益（EPS）-12.91グロス・マージン21.77%純利益率-18.87%有利子負債／自己資本比率159.5%0QQR の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/26 23:32終値2026/05/26 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Gurit Holding AG 3 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。10 アナリスト機関Rupesh MadlaniBarclaysMichael HeiderBerenbergAymeric PoulainBofA Global Research7 その他のアナリストを表示
Buy Or Sell Opportunity • Apr 21Now 22% overvalued after recent price riseOver the last 90 days, the stock has risen 166% to CHF39.00. The fair value is estimated to be CHF31.90, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 13% over the last 3 years. Meanwhile, the company became loss making.
Buy Or Sell Opportunity • Mar 30Now 24% overvalued after recent price riseOver the last 90 days, the stock has risen 228% to CHF37.85. The fair value is estimated to be CHF30.56, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 13% over the last 3 years. Meanwhile, the company became loss making.
お知らせ • Mar 23Gurit Holding AG, Annual General Meeting, Apr 16, 2026Gurit Holding AG, Annual General Meeting, Apr 16, 2026, at 16:30 W. Europe Standard Time.
Reported Earnings • Mar 05Full year 2025 earnings released: CHF12.90 loss per share (vs CHF5.97 loss in FY 2024)Full year 2025 results: CHF12.90 loss per share (further deteriorated from CHF5.97 loss in FY 2024). Revenue: CHF319.6m (down 26% from FY 2024). Net loss: CHF60.3m (loss widened 116% from FY 2024). Revenue is forecast to grow 2.5% p.a. on average during the next 3 years, compared to a 11% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 82 percentage points per year, which is a significant difference in performance.
お知らせ • Dec 16Gurit Holding AG to Report First Half, 2026 Results on Aug 26, 2026Gurit Holding AG announced that they will report first half, 2026 results on Aug 26, 2026
Reported Earnings • Aug 23First half 2025 earnings released: CHF14.59 loss per share (vs CHF0.02 loss in 1H 2024)First half 2025 results: CHF14.59 loss per share (further deteriorated from CHF0.02 loss in 1H 2024). Revenue: CHF164.7m (down 23% from 1H 2024). Net loss: CHF68.2m (loss widened CHF68.1m from 1H 2024). Revenue is expected to fall by 3.5% p.a. on average during the next 3 years compared to a 17% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 91 percentage points per year, which is a significant difference in performance.
Buy Or Sell Opportunity • Apr 21Now 22% overvalued after recent price riseOver the last 90 days, the stock has risen 166% to CHF39.00. The fair value is estimated to be CHF31.90, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 13% over the last 3 years. Meanwhile, the company became loss making.
Buy Or Sell Opportunity • Mar 30Now 24% overvalued after recent price riseOver the last 90 days, the stock has risen 228% to CHF37.85. The fair value is estimated to be CHF30.56, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 13% over the last 3 years. Meanwhile, the company became loss making.
お知らせ • Mar 23Gurit Holding AG, Annual General Meeting, Apr 16, 2026Gurit Holding AG, Annual General Meeting, Apr 16, 2026, at 16:30 W. Europe Standard Time.
Reported Earnings • Mar 05Full year 2025 earnings released: CHF12.90 loss per share (vs CHF5.97 loss in FY 2024)Full year 2025 results: CHF12.90 loss per share (further deteriorated from CHF5.97 loss in FY 2024). Revenue: CHF319.6m (down 26% from FY 2024). Net loss: CHF60.3m (loss widened 116% from FY 2024). Revenue is forecast to grow 2.5% p.a. on average during the next 3 years, compared to a 11% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 82 percentage points per year, which is a significant difference in performance.
お知らせ • Dec 16Gurit Holding AG to Report First Half, 2026 Results on Aug 26, 2026Gurit Holding AG announced that they will report first half, 2026 results on Aug 26, 2026
Reported Earnings • Aug 23First half 2025 earnings released: CHF14.59 loss per share (vs CHF0.02 loss in 1H 2024)First half 2025 results: CHF14.59 loss per share (further deteriorated from CHF0.02 loss in 1H 2024). Revenue: CHF164.7m (down 23% from 1H 2024). Net loss: CHF68.2m (loss widened CHF68.1m from 1H 2024). Revenue is expected to fall by 3.5% p.a. on average during the next 3 years compared to a 17% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 91 percentage points per year, which is a significant difference in performance.
お知らせ • Aug 21Gurit Holding AG to Report Fiscal Year 2025 Final Results on Mar 02, 2026Gurit Holding AG announced that they will report fiscal year 2025 final results at 7:00 AM, Central European Standard Time on Mar 02, 2026
お知らせ • Apr 17Gurit Holding AG Elects Dr. Libo Zhang as New Member of the Board of DirectorsGurit Holding AG at its AGM held on April 15, 2025, the shareholders elected Dr. Libo Zhang as a new member of the Board of Directors.
お知らせ • Apr 01Gurit Holding AG Announces Chief Executive Officer Changes, Effective July 1, 2025Gurit Holding AG announced the appointment of Dr. Tobias Lührig, a German national, as its new Chief Executive Officer, effective July 1, 2025. Dr. Javier Perez-Freije, CFO and current acting CEO ad interim, will continue to lead the company until Tobias Lührig officially starts, after which Javier Perez-Freije will return to the sole role as Chief Financial Officer. With over 20 years of leadership experience in family-owned and private equity-backed companies, Tobias Lührig has a proven track record in operational efficiency, strategic realignment, and margin enhancement. His expertise in right-sizing, fostering resilience during transitions, and aligning global operations makes him the ideal leader for Gurit's ongoing realignment. Tobias Lührig holds a Ph.D. in Mechanical Engineering and an Executive MBA from Harvard Business School. Currently serving as CEO of Bischof+Klein International SE, he combines his engineering, financial, and consulting expertise with a commitment to continuous improvement and corporate culture transformation, which will help to position Gurit for future excellence and growth.
お知らせ • Mar 24Gurit Holding AG, Annual General Meeting, Apr 15, 2025Gurit Holding AG, Annual General Meeting, Apr 15, 2025, at 16:30 W. Europe Standard Time.
Reported Earnings • Mar 06Full year 2024 earnings released: CHF5.97 loss per share (vs CHF1.59 profit in FY 2023)Full year 2024 results: CHF5.97 loss per share (down from CHF1.59 profit in FY 2023). Revenue: CHF431.7m (down 6.1% from FY 2023). Net loss: CHF27.9m (down 475% from profit in FY 2023). Revenue is forecast to grow 1.0% p.a. on average during the next 3 years, compared to a 3.8% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 54 percentage points per year, which is a significant difference in performance.
New Risk • Dec 27New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of British stocks, typically moving 13% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.3x net interest cover). Share price has been highly volatile over the past 3 months (13% average weekly change). Minor Risks Dividend is not well covered by earnings (dividend per share is over 8x earnings per share). Market cap is less than US$100m (CHF71.0m market cap, or US$78.7m).
New Risk • Nov 07New minor risk - Dividend sustainabilityThe dividend is not well covered by earnings. Dividend per share is over 8x earnings per share. Dividend yield: 2.3% This is considered a minor risk. Companies that pay out too much of their earnings are at risk of having to reduce or cut their dividend in future. If earnings growth slows or earnings fall, then there may not be enough earnings to maintain the same dividend. Or in extreme cases, companies may opt to dig into capital reserves or take on debt to maintain the dividend. However, this risk is mitigated by the fact the dividend is covered by cash flows. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.3x net interest cover). Minor Risks Dividend is not well covered by earnings (dividend per share is over 8x earnings per share). Share price has been volatile over the past 3 months (8.4% average weekly change). Market cap is less than US$100m (CHF71.4m market cap, or US$81.4m).
New Risk • Nov 04New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: CHF81.4m (US$94.2m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.3x net interest cover). Minor Risks Share price has been volatile over the past 3 months (8.8% average weekly change). Market cap is less than US$100m (CHF81.4m market cap, or US$94.2m).
お知らせ • Oct 31+ 2 more updatesGurit Holding AG to Report Q3, 2025 Results on Oct 23, 2025Gurit Holding AG announced that they will report Q3, 2025 results at 6:00 PM, Central European Standard Time on Oct 23, 2025
New Risk • Oct 09New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 2.3x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.3x net interest cover). Minor Risk Share price has been volatile over the past 3 months (8.1% average weekly change).
Valuation Update With 7 Day Price Move • Sep 09Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to CHF29.10, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 10x in the Chemicals industry in the United Kingdom. Total loss to shareholders of 84% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CHF53.01 per share.
Valuation Update With 7 Day Price Move • Aug 21Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to CHF35.45, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 10x in the Chemicals industry in the United Kingdom. Total loss to shareholders of 82% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CHF53.03 per share.
New Risk • Aug 05New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of British stocks, typically moving 7.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks High level of debt (74% net debt to equity). Share price has been volatile over the past 3 months (7.0% average weekly change).
Upcoming Dividend • Apr 15Upcoming dividend of CHF0.35 per shareEligible shareholders must have bought the stock before 22 April 2024. Payment date: 24 April 2024. Trailing yield: 0.6%. Lower than top quartile of British dividend payers (6.1%). Lower than average of industry peers (2.9%).
New Risk • Mar 04New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 1.8x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. This is currently the only risk that has been identified for the company.
お知らせ • Sep 23+ 2 more updatesGurit Holding AG to Report First Half, 2024 Results on Aug 19, 2024Gurit Holding AG announced that they will report first half, 2024 results on Aug 19, 2024
Reported Earnings • Aug 31First half 2023 earnings released: EPS: CHF1.54 (vs CHF3.61 in 1H 2022)First half 2023 results: EPS: CHF1.54 (down from CHF3.61 in 1H 2022). Revenue: CHF244.6m (up 4.2% from 1H 2022). Net income: CHF7.19m (down 57% from 1H 2022). Profit margin: 2.9% (down from 7.2% in 1H 2022). Revenue is forecast to grow 5.3% p.a. on average during the next 3 years, compared to a 5.0% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 92 percentage points per year, which is a significant difference in performance.
お知らせ • Aug 18Gurit Holding AG (SWX:GURN) acquired additional 40% stake in Fiberline Building Profiles A/S from Thorning family for €28.15 million.Gurit Holding AG (SWX:GURN) acquired additional 40% stake in Fiberline Building Profiles A/S from Thorning family for €28.15 million on August 15, 2023. The purchase price of €28.15 million includes a cash consideration and a longer term earn-out.Gurit Holding AG (SWX:GURN) completed the acquisition of additional 40% stake in Fiberline Building Profiles A/S from Thorning family on August 15, 2023.
お知らせ • Nov 25+ 1 more updateGurit Holding AG to Report First Half, 2023 Results on Aug 16, 2023Gurit Holding AG announced that they will report first half, 2023 results on Aug 16, 2023
Board Change • Nov 16No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 6 non-independent directors. Director Andreas Evertz was the last director to join the board, commencing their role in 2022. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
Valuation Update With 7 Day Price Move • Oct 18Investor sentiment improved over the past weekAfter last week's 19% share price gain to CHF97.50, the stock trades at a forward P/E ratio of 27x. Average forward P/E is 16x in the Chemicals industry in the United Kingdom. Total loss to shareholders of 24% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CHF110 per share.
Valuation Update With 7 Day Price Move • Sep 29Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to CHF70.30, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 17x in the Chemicals industry in the United Kingdom. Total loss to shareholders of 45% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CHF116 per share.
Buying Opportunity • Sep 05Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 8.3%. The fair value is estimated to be CHF120, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 5.1% over the last 3 years. Earnings per share has declined by 64%. Revenue is forecast to grow by 37% in 2 years. Earnings is forecast to grow by 39% in the next 2 years.
Reported Earnings • Aug 19First half 2022 earnings releasedFirst half 2022 results: Revenue: CHF234.8m (down 9.2% from 1H 2021). Net income: CHF16.9m (up 41% from 1H 2021). Profit margin: 7.2% (up from 4.6% in 1H 2021). Over the next year, revenue is forecast to grow 17% compared to a 21% decline forecast for the Chemicals industry in the United Kingdom.
お知らせ • Jul 09+ 1 more updateGurit Holding AG to Report Fiscal Year 2022 Results on Jan 30, 2023Gurit Holding AG announced that they will report fiscal year 2022 results on Jan 30, 2023
Board Change • Apr 27No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 6 non-independent directors. Director Andreas Evertz was the last director to join the board, commencing their role in 2022. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
Upcoming Dividend • Apr 15Upcoming dividend of CHF7.00 per shareEligible shareholders must have bought the stock before 22 April 2022. Payment date: 26 April 2022. Payout ratio is a comfortable 29% but the company is not cash flow positive. Trailing yield: 0.5%. Lower than top quartile of British dividend payers (4.6%). Lower than average of industry peers (2.6%).
Valuation Update With 7 Day Price Move • Mar 03Investor sentiment improved over the past weekAfter last week's 16% share price gain to CHF1,520, the stock trades at a forward P/E ratio of 29x. Average forward P/E is 20x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 56% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CHF610 per share.
Reported Earnings • Mar 02Full year 2021 earnings: Revenues in line with analyst expectationsFull year 2021 results: Revenue: CHF467.9m (down 19% from FY 2020). Net income: CHF11.4m (down 76% from FY 2020). Profit margin: 2.4% (down from 8.1% in FY 2020). The decrease in margin was driven by lower revenue. Revenue was in line with analyst estimates. Over the next year, revenue is forecast to grow 3.6% compared to a 3.9% decline forecast for the industry in the United Kingdom.
Board Change • Sep 25No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 6 non-independent directors. Non-Executive Director Rudolf Hadorn was the last director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
Upcoming Dividend • Apr 09Upcoming dividend of CHF30.00 per shareEligible shareholders must have bought the stock before 16 April 2021. Payment date: 20 April 2021. Trailing yield: 1.2%. Lower than top quartile of British dividend payers (4.2%). Lower than average of industry peers (1.6%).
Is New 90 Day High Low • Mar 05New 90-day low: CHF2,255The company is down 6.0% from its price of CHF2,395 on 04 December 2020. The British market is up 4.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 15% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CHF1,069 per share.
Reported Earnings • Mar 04Full year 2020 earnings released: EPS CHF99.28 (vs CHF96.83 in FY 2019)The company reported a solid full year result with improved earnings and revenues, although profit margins were flat. Full year 2020 results: Revenue: CHF576.7m (up 3.3% from FY 2019). Net income: CHF46.4m (up 2.6% from FY 2019). Profit margin: 8.1% (in line with FY 2019). Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has increased by 36% per year, which means it is tracking significantly ahead of earnings growth.
Analyst Estimate Surprise Post Earnings • Mar 04Revenue misses expectationsRevenue missed analyst estimates by 1.1%. Over the next year, revenue is forecast to grow 2.3% compared to a 12% decline forecast for the Chemicals industry in the United Kingdom.
Is New 90 Day High Low • Jan 14New 90-day high: CHF2,690The company is up 33% from its price of CHF2,015 on 16 October 2020. The British market is up 14% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 10.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CHF2,057 per share.
Is New 90 Day High Low • Dec 29New 90-day high: CHF2,500The company is up 31% from its price of CHF1,910 on 29 September 2020. The British market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 11% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CHF2,024 per share.
お知らせ • Dec 12Gurit Holding AG to Report First Half, 2021 Results on Aug 17, 2021Gurit Holding AG announced that they will report first half, 2021 results on Aug 17, 2021
お知らせ • Dec 11Gurit Holding AG to Report Fiscal Year 2020 Results on Mar 02, 2021Gurit Holding AG announced that they will report fiscal year 2020 results at 7:00 AM, Central European Standard Time on Mar 02, 2021
Valuation Update With 7 Day Price Move • Dec 10Market pulls back on stock over the past weekAfter last week's 61% share price decline to CHF879, the stock is trading at a trailing P/E ratio of 25x, down from the previous P/E ratio of 64.5x. This compares to an average P/E of 40x in the Chemicals industry in the United Kingdom. Total return to shareholders over the past three years is a loss of 6.1%.
Valuation Update With 7 Day Price Move • Dec 07Market pulls back on stock over the past weekAfter last week's 61% share price decline to CHF879, the stock is trading at a trailing P/E ratio of 24.7x, down from the previous P/E ratio of 64x. This compares to an average P/E of 39x in the Chemicals industry in the United Kingdom. Total return to shareholders over the past three years is a loss of 6.1%.
Valuation Update With 7 Day Price Move • Nov 30Market pulls back on stock over the past weekAfter last week's 58% share price decline to CHF879, the stock is trading at a trailing P/E ratio of 22.7x, down from the previous P/E ratio of 53.6x. This compares to an average P/E of 38x in the Chemicals industry in the United Kingdom. Total return to shareholders over the past three years is a loss of 8.3%.
Valuation Update With 7 Day Price Move • Nov 26Market pulls back on stock over the past weekAfter last week's 57% share price decline to CHF879, the stock is trading at a trailing P/E ratio of 20.9x, down from the previous P/E ratio of 48.7x. This compares to an average P/E of 37x in the Chemicals industry in the United Kingdom. Total return to shareholders over the past three years is a loss of 9.1%.
Valuation Update With 7 Day Price Move • Nov 20Market pulls back on stock over the past weekAfter last week's 54% share price decline to CHF879, the stock is trading at a trailing P/E ratio of 21.1x, down from the previous P/E ratio of 45.7x. This compares to an average P/E of 39x in the Chemicals industry in the United Kingdom. Total return to shareholders over the past three years is a loss of 8.6%.
Is New 90 Day High Low • Nov 20New 90-day low: CHF879The company is down 48% from its price of CHF1,688 on 20 August 2020. The British market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 8.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CHF767 per share.
Valuation Update With 7 Day Price Move • Nov 13Market pulls back on stock over the past weekAfter last week's 56% share price decline to CHF879, the stock is trading at a trailing P/E ratio of 19.6x, down from the previous P/E ratio of 45x. This compares to an average P/E of 39x in the Chemicals industry in the United Kingdom. Total return to shareholders over the past three years is a loss of 7.7%.
Valuation Update With 7 Day Price Move • Nov 07Market pulls back on stock over the past weekAfter last week's 54% share price decline to CHF879, the stock is trading at a trailing P/E ratio of 20.6x, down from the previous P/E ratio of 45.1x. This compares to an average P/E of 39x in the Chemicals industry in the United Kingdom. Total return to shareholders over the past three years is a loss of 17%.
Is New 90 Day High Low • Oct 30New 90-day low: CHF879The company is down 46% from its price of CHF1,616 on 30 July 2020. The British market is down 4.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 4.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CHF811 per share.
Valuation Update With 7 Day Price Move • Oct 30Market pulls back on stock over the past weekAfter last week's 56% share price decline to CHF879, the stock is trading at a trailing P/E ratio of 19.8x, down from the previous P/E ratio of 45.1x. This compares to an average P/E of 38x in the Chemicals industry in the United Kingdom. Total return to shareholders over the past three years is a loss of 17%.
Is New 90 Day High Low • Oct 01New 90-day high: CHF2,025The company is up 45% from its price of CHF1,398 on 03 July 2020. The British market is down 4.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 12% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CHF1,867 per share.
お知らせ • Aug 17Gurit Announces the Appointment of Mitja Schulz as Chief Executive OfficerGurit announced the appointment of Mitja Schulz as Chief Executive Officer and Member of the Executive Committee. As communicated on April 23, 2020, Gurit has been in the process of recruiting the successor of current Chief Executive Officer Rudolf Hadorn. On August 17, 2020, it was announced that Mitja Schulz has been appointed to fill the position. Prior to joining Gurit, Mitja Schulz was Senior Vice President and CEO of ZF Wind Power Antwerpen NV, part of ZF Friedrichshafen. Before this, he held a number of senior management positions within ZF Friedrichshafen and Porschewhere he successfully executed major business transformation and growth programs.
